New Issue: Science’s Impossible Questions. Read Now

Making Fat-proof Mice

Join Our Community of Science Lovers!

Source: courtesy of Baylor College of Medicine

As most dieters will tell you, fat is stubborn stuff. For individuals genetically predisposed to obesity, this fact is particularly worrisome. But findings published in the December issue of the journal Nature Genetics could eventually help fight obesity. The key, researchers say, may be targeting a fat-protecting protein known as perilipin.

Earlier studies had suggested that perilipin was involved in lipid maintenance and energy metabolism. So Lawrence Chan of Baylor College of Medicine and his colleagues set out to clarify the protein's role by genetically engineering a line of mice in which the gene that codes for perilipin had been inactivated. The team found that in comparison to normal mice (A), the perilipin-free mice had about half as much body fat, 8 percent more muscle and a consistently higher metabolic rate--despite eating 25 percent more food and leading sedentary lives. Furthermore, fat cells in perilipin-free mice were half as large as those in the normal mice. The researchers also examined the effects of perilipin in mice genetically programmed to be obese. There again the results were dramatic: the mice lacking perilipin (B) grew up to be lean and healthy, in contrast to those that produced the protein (C).


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


"Perilipin works by coating the surface of fat storage droplets inside fat cells, protecting them from hormone-sensitive lipase, HSL, a fat-metabolizing enzyme," Chan explains. Without perilipin, HSL burns the fat right away. "These results are very exciting because not only is perilipin active in humans, it is made almost exclusively by fat cells," he notes. Thus, drugs that target perilipin could potentially have fewer side effects than anti-obesity drugs that affect the brain or other organs. But as promising as the perilipin research seems, Chan cautions that "it will take time to move perilipin research from experiments in mice to helping humans with weight problems."

Kate Wong is an award-winning science writer and was formerly senior editor for features at Scientific American, where she focused on evolution, ecology, anthropology, archaeology, paleontology and animal behavior. She is fascinated by human origins, which she has covered for nearly 30 years. Recently she has become obsessed with birds. Her reporting has taken her to caves in France and Croatia that Neandertals once called home to the shores of Kenya’s Lake Turkana in search of the oldest stone tools in the world, as well as to Madagascar on an expedition to unearth ancient mammals and dinosaurs, the icy waters of Antarctica, where humpback whales feast on krill, and a “Big Day” race around the state of Connecticut to find as many bird species as possible in 24 hours. Wong is co-author, with Donald Johanson, of Lucy’s Legacy: The Quest for Human Origins. She holds a bachelor of science degree in biological anthropology and zoology from the University of Michigan. Follow her on Bluesky @katewong.bsky.social

More by Kate Wong

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe